In a patient who meets criteria for major depressive disorder and has panic symptoms that do not meet full criteria for panic disorder, should an Other Specified Anxiety Disorder (panic attacks) diagnosis be added alongside MDD, or can the anxiety symptoms be considered part of the depressive disorder?

Should You Diagnose Other Specified Anxiety Disorder Alongside MDD for Subthreshold Panic Symptoms?

When a patient meets full criteria for MDD but has panic symptoms that don't meet full panic disorder criteria, you should use the DSM-5 "anxious distress" specifier for MDD rather than adding a separate Other Specified Anxiety Disorder diagnosis.

The DSM-5 Anxious Distress Specifier Approach

The DSM-5 introduced the "anxious distress" specifier specifically to capture anxiety symptoms within MDD without requiring a separate anxiety disorder diagnosis 1. This approach is clinically superior because:

• The anxious distress specifier has stronger predictive validity than comorbid anxiety disorder diagnoses for clinical outcomes in MDD patients 2
• It significantly predicts 2-year chronicity (OR = 1.96), time to remission (HR = 0.75), and functional disability—all outperforming DSM-IV anxiety disorder diagnoses 2
• The specifier is present in approximately 50-75% of MDD patients 3, making it the norm rather than the exception

Why Separate Anxiety Diagnoses Are Often Inappropriate

The high comorbidity between MDD and anxiety disorders (estimated at 56%) is largely driven by overlapping diagnostic criteria rather than true separate conditions 4. Research demonstrates:

• GAD and MDD share four overlapping symptoms in DSM criteria, and comorbidity is strongly influenced by this diagnostic overlap 5
• When controlling for symptom overlap, patients don't show distinct symptom profiles that would justify separate diagnoses 6
• The comorbid group endorses overlapping symptoms more than non-overlapping ones, suggesting artificial inflation of comorbidity rates 5

Clinical Decision Algorithm

Use this approach:

1. Confirm full MDD criteria are met (5+ symptoms including depressed mood or anhedonia for 2+ weeks)

2. Assess for panic symptoms - Look for:

   • Abrupt surges of intense fear
   • Physical symptoms (palpitations, sweating, trembling, shortness of breath)
   • Cognitive symptoms (fear of losing control, fear of dying)

3. Determine if panic disorder criteria are met:

   • Recurrent unexpected panic attacks (not just situational)
   • Persistent concern about additional attacks or maladaptive behavioral changes
   • If YES → Diagnose both MDD and Panic Disorder
   • If NO → Continue to step 4

4. Apply the anxious distress specifier to MDD if 2+ of these are present:

   • Feeling keyed up or tense
   • Feeling unusually restless
   • Difficulty concentrating due to worry
   • Fear that something awful may happen
   • Feeling of losing control

5. Code as: Major Depressive Disorder with anxious distress (mild, moderate, or severe based on number of symptoms)

Critical Clinical Implications

Patients with MDD and anxiety symptoms have significantly worse outcomes 3:

• Substantially poorer psychosocial functioning and quality of life
• Take significantly longer to achieve remission
• Less likely to achieve remission overall

Therefore, the presence of anxiety symptoms (even subthreshold) demands more aggressive treatment, but this is accomplished through the specifier notation rather than adding diagnoses that may not represent distinct pathological entities.

Common Pitfalls to Avoid

Don't over-diagnose separate anxiety disorders when symptoms are better explained as part of the depressive syndrome. The key distinguishing feature is whether panic attacks are truly unexpected and recurrent (panic disorder) versus occurring in the context of depressive rumination or worry.

Don't under-recognize the clinical significance of anxiety symptoms just because they don't meet full disorder criteria. The anxious distress specifier captures clinically meaningful anxiety that affects prognosis and should influence treatment intensity 2.

Remember that approximately 60-70% of patients with comorbid anxiety and depression experience anxiety first 3, but this temporal sequence alone doesn't mandate separate diagnoses—it may represent a prodrome of the depressive episode.

Treatment Implications

The anxious distress specifier should guide you toward:

• SSRIs or SNRIs as first-line pharmacotherapy (effective for both depression and anxiety) 7, 4
• Cognitive behavioral therapy, which addresses both symptom domains 8
• More frequent monitoring in the first 1-2 weeks 7
• Recognition that remission may take longer than MDD without anxiety 3